A recent study reported decreased OTC expression in HCC patients’ samples; OTC is one of the characteristic arginine metabolism genes in pediatric sarcomas, brain tumors, and acute lymphoblastic leukemia [67,68]. This evidence concerns the gene OTC and hepatocellular carcinoma.